Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02655354 · ClinicalTrials.gov registry record · NA
A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 635
- Enrollment target
NCT02655354 is a NA study that has completed, run by University of Washington. The registered enrollment target is 635 participants.
The verdict
NCT02655354, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 635 participants
- Enrollment target
Study Summary
The overarching goal of this UH2-UH3 proposal is to work with the NIH Health Care Systems Research Collaboratory to develop and implement a large scale, cluster randomized pragmatic clinical trial demonstration project that directly informs national trauma care system policy targeting injured patients with presentations of Posttraumatic Stress Disorder (PTSD) and related comorbidity. Each year in the United States (US), over 30 million individuals present to trauma centers, emergency departments, and other acute care medical settings for the treatment of physical injuries. Multiple chronic conditions including enduring PTSD, alcohol and drug use problems, depression and associated suicidal ideation, pain and somatic symptom amplification, and chronic medical conditions (e.g., hypertension, coronary artery disease, diabetes, and pulmonary diseases) are endemic among physical trauma survivors with and without traumatic brain injuries (TBI). Evidence-based, collaborative care/care management treatment models for PTSD and related comorbidities exist. These care management models have the potential to be flexibly implemented in order to prevent the development of chronic PTSD and depressive symptoms, alcohol use problems, and enduring physical disability in survivors of both TBI and non-TBI injuries; care management models may also be effective in mitigating the impact of the acute injury event on symptom exacerbations in the large subpopulation of injury survivors who already carry a substantial pre-injury burden of multiple chronic medical conditions.
Interventions
- BEHAVIORAL Motivational Interviewing
- DRUG Fluoxetine
- DRUG Fluvoxamine
- BEHAVIORAL Cognitive Behavioral Therapy Elements
- BEHAVIORAL Care Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 635 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02655354
The ClinicalTrials.gov registry entry for NCT02655354 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 635 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Motivational Interviewing is the first listed.
NCT02655354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02655354 about?
NCT02655354 is a clinical study titled "A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity". The overarching goal of this UH2-UH3 proposal is to work with the NIH Health Care Systems Research Collaboratory to develop and implement a large scale, cluster randomized pragmatic clinical trial demonstration project that directly informs national trauma care system policy targeting injured patien...
What is the current status of trial NCT02655354?
This trial is currently completed. It is a NA study. The enrollment target is 635 participants. The study started on 2015-10. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02655354?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Fluoxetine (DRUG), Fluvoxamine (DRUG), Cognitive Behavioral Therapy Elements (BEHAVIORAL), Care Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT02655354?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.